Jennifer Champagne, PharmD, RPh, BCPS

Researchers examined the effects of the COVID-19 pandemic on individuals with nonalcoholic fatty liver disease and alcohol-associated liver disease.

Researchers analyzed whether food intake parameters, such as hunger and hedonic eating, were associated with gastrointestinal symptoms in obesity.

Researchers sought to estimate the worldwide prevalence and incidence of nonalcoholic fatty liver disease.

Investigators assessed the incidence of major adverse cardiovascular events in patients with histologically-confirmed nonalcoholic fatty liver disease.

An international panel proposed updated criteria for disease diagnosis, along with a more age-appropriate disease name and definition, for pediatric patients with NAFLD.

Investigators reviewed the connection between communication skills and patient satisfaction and offered recommendations for improving the patient-provider relationship.

Investigators assessed the outcomes of SARS-CoV-2 positivity in patients with chronic liver diseases and cirrhosis.